Treatment of gastrointestinal ischemic injury.

The study discusses the causes and treatments of gastrointestinal ischemic injury, primarily in horses, emphasizing the role of reperfusion injury, intraluminal solutions, and the exploration of drugs like flunixin meglumine.

Understanding Gastrointestinal Ischemic Injury

• Gastrointestinal ischemic injury often leads to high mortality in equine veterinary medicine. The condition occurs when the blood flow to an area of the digestive tract is cut off, commonly from a blockage in the blood vessels leading to the gut.
• One of the primary issues in this injury is reperfusion injury. This occurs when the blood supply returns to the tissue after a period of ischemia or lack of oxygen. The return of blood flow can cause inflammation and oxidative damage rather than restoring normal function.

Experimental Trials for Treatment

• While various experimental trials have been conducted to mitigate the damage from reperfusion injury, none have translated into clinically effective treatments yet. The challenge lies in minimizing the level of injury following an ischemic episode.
• Recent research suggests that using solutions containing antioxidants, nutrients, and vasodilators applied directly within the lumen of the gut might hold promise. These solutions could potentially minimize inflammation and oxidative stress, promoting recovery.

Improving Mucosal Recovery

• The study proposes an alternative method of treatment – focusing on improving the recovery of the mucosa (the innermost layer of the gastrointestinal tract) following an ischemic event. This could contribute to lowering the risk of mortality.
• This approach includes the administration of components of the basement membrane like hyaluronic acid which aids in tissue repair. It also involves gut-specific nutrients such as glutamine, and an early return to feeding to stimulate the body’s natural repair mechanisms.

Evaluating NSAIDs and Flunixin Meglumine

• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), specifically flunixin meglumine, are explored as treatment options. These drugs are often used in veterinary medicine for their pain-relieving, anti-inflammatory, and fever-reducing capabilities.
• The study, however, revealed that flunixin meglumine could potentially delay the repair process of the gut mucosa. This revelation underscores the importance of carefully considering the use of this medication.